Human Gene RP11-794P6.8 (uc001pll.3)
|
|
Sequence and Links to Tools and Databases
|
|
Primer design for this transcript
|
|
Microarray Expression Data
|
|
Press "+" in the title bar above to open this section.
| |
|
|
Orthologous Genes in Other Species
|
|
Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
Mouse | Rat | Zebrafish | D. melanogaster | C. elegans | S. cerevisiae |
No ortholog | No ortholog | No ortholog | No ortholog | No ortholog | No ortholog |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
|
| |
|
|
Descriptions from all associated GenBank mRNAs
|
|
BC021736 - Homo sapiens cDNA clone IMAGE:4820483. CS266558 - Sequence 250 from Patent WO2005118806. DL076720 - METHODS AND COMPOSITIONS INVOLVING MicroRNA. DM004370 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. FW421712 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HW367583 - JP 2012228254-A/250: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HW411976 - JP 2014000079-A/250: METHODS AND COMPOSITIONS INVOLVING MicroRNA. HW674322 - JP 2014217381-A/250: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HZ067264 - JP 2014012020-A/250: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HZ427688 - JP 2014217384-A/250: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HZ428491 - JP 2014217385-A/250: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HZ429294 - JP 2014217386-A/250: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HZ430097 - JP 2014217387-A/250: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HZ769354 - JP 2014223080-A/250: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. JA058748 - Sequence 250 from Patent EP2298893. JA059551 - Sequence 250 from Patent EP2298894. JA073874 - Sequence 250 from Patent EP2281887. JA105011 - Sequence 250 from Patent EP2302051. JA106351 - Sequence 250 from Patent EP2302052. JA107154 - Sequence 250 from Patent EP2302053. JA107957 - Sequence 250 from Patent EP2302054. JA108760 - Sequence 250 from Patent EP2302055. JA109563 - Sequence 250 from Patent EP2302056. JA192079 - Sequence 250 from Patent EP2290066. JA192978 - Sequence 250 from Patent EP2290067. JA193877 - Sequence 250 from Patent EP2290068. JA194776 - Sequence 250 from Patent EP2290069. JA195675 - Sequence 250 from Patent EP2290070. JA196574 - Sequence 250 from Patent EP2290071. JA197473 - Sequence 250 from Patent EP2290072. JA198372 - Sequence 250 from Patent EP2290073. JA199271 - Sequence 250 from Patent EP2290074. JA200170 - Sequence 250 from Patent EP2290075. JA201069 - Sequence 250 from Patent EP2290076. JA218191 - Sequence 250 from Patent EP2281888. JA226342 - Sequence 250 from Patent EP2292755. JA229197 - Sequence 250 from Patent EP2292756. JA257468 - Sequence 250 from Patent EP2284265. JA278748 - Sequence 250 from Patent EP2281886. JA284634 - Sequence 250 from Patent EP2281889. JA292687 - Sequence 250 from Patent EP2287303. JA317873 - Sequence 250 from Patent EP2314688. JA374932 - Sequence 250 from Patent EP2322616. JC221775 - Sequence 250 from Patent EP2471923. JC268341 - Sequence 250 from Patent EP2471924. JC340649 - Sequence 250 from Patent EP2471922. JC469895 - Sequence 250 from Patent EP2471921. JC990684 - Sequence 250 from Patent EP2808390. LF714787 - JP 2016165292-A/250: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. LF856721 - JP 2015142597-A/250: METHODS AND COMPOSITIONS INVOLVING MicroRNA. CS266368 - Sequence 60 from Patent WO2005118806. DL076530 - METHODS AND COMPOSITIONS INVOLVING MicroRNA. DM004180 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. FU261117 - MICRORNA EXPRESSION ABNORMALITIES IN PANCREATIC ENDOCRINE AND ACINAR TUMORS. FU763619 - MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS. FV527354 - Nucleic acid controling mast cell degranulation. FW421522 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. FW504788 - COMPOSITIONS COMPRISING MIR34 THERAPEUTIC AGENTS FOR TREATING CANCER. HI508139 - Sequence 8 from Patent EP2152722. HV304518 - JP 2009531018-A/85: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF LUNG CANCER. HV305016 - JP 2009531019-A/85: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS. HV325292 - JP 2011505853-A/1: METHOD FOR REPROGRAMING IN VITRO STEM CELLS AND SOMATIC CELLS INTO GERMINAL CELLS. HV444476 - JP 2011515078-A/8: TREATMENT, DIAGNOSTIC, AND METHOD FOR DISCOVERING ANTAGONIST USING SPARC SPECIFIC MIRNAS. HW102017 - JP 2013500034-A/144: Use of microRNA for treating diseases associated with a dysfunction of the cilia in multiciliated epithelial cells. HW119225 - JP 2013046612-A/85: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS. HW367393 - JP 2012228254-A/60: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HW411786 - JP 2014000079-A/60: METHODS AND COMPOSITIONS INVOLVING MicroRNA. HW505135 - JP 2014502606-A/37: MELANOMA TREATMENTS. HW589554 - JP 2013121348-A/85: MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS. HW674132 - JP 2014217381-A/60: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HZ043219 - JP 2015510401-A/309: MESENCHYMAL STEM CELLS FOR IN VITRO MODELING AND CELL-BASED THERAPY OF HUMAN DISEASES AND BANKS THEREOF. HZ067074 - JP 2014012020-A/60: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HZ081845 - JP 2015514392-A/309: MicroRNAS FOR THE GENERATION OF ASTROCYTES. HZ408235 - JP 2015528002-A/832: CHIRAL CONTROL. HZ413358 - JP 2014060993-A/85: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS. HZ427498 - JP 2014217384-A/60: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HZ428301 - JP 2014217385-A/60: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HZ429104 - JP 2014217386-A/60: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HZ429907 - JP 2014217387-A/60: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HZ501569 - JP 2016025853-A/85: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS. HZ769164 - JP 2014223080-A/60: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. JA058558 - Sequence 60 from Patent EP2298893. JA059361 - Sequence 60 from Patent EP2298894. JA073684 - Sequence 60 from Patent EP2281887. JA104821 - Sequence 60 from Patent EP2302051. JA106161 - Sequence 60 from Patent EP2302052. JA106964 - Sequence 60 from Patent EP2302053. JA107767 - Sequence 60 from Patent EP2302054. JA108570 - Sequence 60 from Patent EP2302055. JA109373 - Sequence 60 from Patent EP2302056. JA191889 - Sequence 60 from Patent EP2290066. JA192788 - Sequence 60 from Patent EP2290067. JA193687 - Sequence 60 from Patent EP2290068. JA194586 - Sequence 60 from Patent EP2290069. JA195485 - Sequence 60 from Patent EP2290070. JA196384 - Sequence 60 from Patent EP2290071. JA197283 - Sequence 60 from Patent EP2290072. JA198182 - Sequence 60 from Patent EP2290073. JA199081 - Sequence 60 from Patent EP2290074. JA199980 - Sequence 60 from Patent EP2290075. JA200879 - Sequence 60 from Patent EP2290076. JA218001 - Sequence 60 from Patent EP2281888. JA226152 - Sequence 60 from Patent EP2292755. JA229007 - Sequence 60 from Patent EP2292756. JA257278 - Sequence 60 from Patent EP2284265. JA278558 - Sequence 60 from Patent EP2281886. JA284444 - Sequence 60 from Patent EP2281889. JA292497 - Sequence 60 from Patent EP2287303. JA317683 - Sequence 60 from Patent EP2314688. JA374742 - Sequence 60 from Patent EP2322616. JA525935 - Sequence 85 from Patent EP2369011. JA526442 - Sequence 85 from Patent EP2369012. JA526949 - Sequence 85 from Patent EP2369013. JA535878 - Sequence 85 from Patent EP2371971. JA787883 - Sequence 85 from Patent EP2479285. JA788381 - Sequence 85 from Patent EP2479286. JA810715 - Sequence 85 from Patent EP2468890. JA811213 - Sequence 85 from Patent EP2468891. JA811711 - Sequence 85 from Patent EP2468893. JA812209 - Sequence 85 from Patent EP2468894. JA812707 - Sequence 85 from Patent EP2468895. JA813205 - Sequence 85 from Patent EP2468896. JA813703 - Sequence 85 from Patent EP2468897. JA814201 - Sequence 85 from Patent EP2468898. JA814699 - Sequence 85 from Patent EP2468899. JA816942 - Sequence 85 from Patent EP2468892. JA825754 - Sequence 85 from Patent EP2471956. JA826252 - Sequence 85 from Patent EP2471958. JB024539 - Sequence 85 from Patent EP2505668. JB025037 - Sequence 85 from Patent EP2505669. JB079424 - Sequence 85 from Patent EP2487252. JB079922 - Sequence 85 from Patent EP2487253. JB080420 - Sequence 85 from Patent EP2487254. JB080918 - Sequence 85 from Patent EP2487255. JB081416 - Sequence 85 from Patent EP2487256. JB081914 - Sequence 85 from Patent EP2487257. JB082412 - Sequence 85 from Patent EP2487258. JB082910 - Sequence 85 from Patent EP2487259. JB083408 - Sequence 85 from Patent EP2487260. JB083906 - Sequence 85 from Patent EP2487261. JB084404 - Sequence 85 from Patent EP2487262. JB084902 - Sequence 85 from Patent EP2487263. JB087580 - Sequence 85 from Patent EP2502630. JB147784 - Sequence 85 from Patent EP2484782. JB148282 - Sequence 85 from Patent EP2484783. JB153007 - Sequence 85 from Patent EP2514433. JB153505 - Sequence 85 from Patent EP2514434. JB622094 - Sequence 85 from Patent EP2586454. JB622592 - Sequence 85 from Patent EP2586455. JC001655 - Sequence 85 from Patent EP2591794. JC037593 - Sequence 121 from Patent EP2643479. JC221585 - Sequence 60 from Patent EP2471923. JC268151 - Sequence 60 from Patent EP2471924. JC340459 - Sequence 60 from Patent EP2471922. JC469705 - Sequence 60 from Patent EP2471921. JC572002 - Sequence 16 from Patent EP2759595. JC990494 - Sequence 60 from Patent EP2808390. LF132451 - JP 2016506923-A/16: Composition comprising an encapsulated antagomir. LF404316 - JP 2015509366-A/309: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS. LF714597 - JP 2016165292-A/60: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. LF856531 - JP 2015142597-A/60: METHODS AND COMPOSITIONS INVOLVING MicroRNA. LG051569 - KR 1020150036642-A/835: CHIRAL CONTROL. LG162315 - KR 1020160018451-A/16: Composition comprising an encapsulated antagomir. MA353847 - JP 2018075017-A/309: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS. MS810732 - Sequence 2 from Patent EP3142707. CQ873622 - Sequence 41 from Patent WO2004076622. DD413459 - Regulation of Mammalian Cells. DJ003844 - Method for predicting or identifying target mRNAs of functional RNAs and use thereof. DJ027123 - Method for predicting or identifying target mRNAs of functional RNAs and use thereof. FU261390 - MICRORNA EXPRESSION ABNORMALITIES IN PANCREATIC ENDOCRINE AND ACINAR TUMORS. FU763892 - MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS. FW504787 - COMPOSITIONS COMPRISING MIR34 THERAPEUTIC AGENTS FOR TREATING CANCER. HH981320 - Sequence 80 from Patent EP1723162. HI508138 - Sequence 7 from Patent EP2152722. HV304791 - JP 2009531018-A/358: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF LUNG CANCER. HV305289 - JP 2009531019-A/358: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS. HV954028 - JP 2012518421-A/940: METHODS OF DETECTING LUNG CANCER. HW119498 - JP 2013046612-A/358: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS. HW589827 - JP 2013121348-A/358: MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS. HZ413631 - JP 2014060993-A/358: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS. HZ501842 - JP 2016025853-A/358: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS. JA526208 - Sequence 358 from Patent EP2369011. JA526715 - Sequence 358 from Patent EP2369012. JA527222 - Sequence 358 from Patent EP2369013. JA536151 - Sequence 358 from Patent EP2371971. JA715158 - Sequence 940 from Patent EP2401406. JA788156 - Sequence 358 from Patent EP2479285. JA788654 - Sequence 358 from Patent EP2479286. JA810988 - Sequence 358 from Patent EP2468890. JA811486 - Sequence 358 from Patent EP2468891. JA811984 - Sequence 358 from Patent EP2468893. JA812482 - Sequence 358 from Patent EP2468894. JA812980 - Sequence 358 from Patent EP2468895. JA813478 - Sequence 358 from Patent EP2468896. JA813976 - Sequence 358 from Patent EP2468897. JA814474 - Sequence 358 from Patent EP2468898. JA814972 - Sequence 358 from Patent EP2468899. JA817215 - Sequence 358 from Patent EP2468892. JA826027 - Sequence 358 from Patent EP2471956. JA826525 - Sequence 358 from Patent EP2471958. JB024812 - Sequence 358 from Patent EP2505668. JB025310 - Sequence 358 from Patent EP2505669. JB079697 - Sequence 358 from Patent EP2487252. JB080195 - Sequence 358 from Patent EP2487253. JB080693 - Sequence 358 from Patent EP2487254. JB081191 - Sequence 358 from Patent EP2487255. JB081689 - Sequence 358 from Patent EP2487256. JB082187 - Sequence 358 from Patent EP2487257. JB082685 - Sequence 358 from Patent EP2487258. JB083183 - Sequence 358 from Patent EP2487259. JB083681 - Sequence 358 from Patent EP2487260. JB084179 - Sequence 358 from Patent EP2487261. JB084677 - Sequence 358 from Patent EP2487262. JB085175 - Sequence 358 from Patent EP2487263. JB087853 - Sequence 358 from Patent EP2502630. JB148057 - Sequence 358 from Patent EP2484782. JB148555 - Sequence 358 from Patent EP2484783. JB153280 - Sequence 358 from Patent EP2514433. JB153778 - Sequence 358 from Patent EP2514434. JB256161 - Sequence 80 from Patent EP2327710. JB622367 - Sequence 358 from Patent EP2586454. JB622865 - Sequence 358 from Patent EP2586455. JC001928 - Sequence 358 from Patent EP2591794. CS548419 - Sequence 1449 from Patent EP1777301. FU757832 - Method for detection of cancer. FV524043 - Diagnosis and therapeutic choice of gynecologic cancer using micro RNA as biomarker. FV525597 - Nucleic acid controling mast cell degranulation. FW312161 - DETECTING NUCLEIC ACIDS. FW364249 - Oligonucleotides for modulating target RNA activity. FW393832 - Diagnosis and therapeutic choice of gynecologic cancer using micro RNA as biomarker. HI965148 - Sequence 433 from Patent WO2010139812. HI966155 - Sequence 475 from Patent WO2010139811. HI967021 - Sequence 475 from Patent WO2010139810. HV321529 - JP 2011072229-A/36: Diagnosis and therapeutic choice of hypopharyngeal cancer using micro RNA as biomarker. HV325293 - JP 2011505853-A/2: METHOD FOR REPROGRAMING IN VITRO STEM CELLS AND SOMATIC CELLS INTO GERMINAL CELLS. HV444516 - JP 2011515078-A/48: TREATMENT, DIAGNOSTIC, AND METHOD FOR DISCOVERING ANTAGONIST USING SPARC SPECIFIC MIRNAS. HV534434 - WO 2011111715-A/950: Nucleic acid for controlling cell cycle. HV593844 - JP 2010538610-A/57: MICRORNA SIGNATURES IN HUMAN OVARIAN CANCER. HV595158 - JP 2010539959-A/539: Micromirs. HV753798 - JP 2012509675-A/36: COMPOSITIONS AND METHODS FOR DETECTING SMALL RNAS, AND USES THEREOF. HW060377 - JP 2012527478-A/41: Identification of MicroRNAs Involved in Post-Myocardial Infarction Remodeling and Heart Failure. HW101913 - JP 2013500034-A/40: Use of microRNA for treating diseases associated with a dysfunction of the cilia in multiciliated epithelial cells. HW505324 - JP 2014502606-A/226: MELANOMA TREATMENTS. HW612386 - JP 2014140377-A/4: Method for detection of cancer. HW915079 - JP 2015504655-A/37: METHODS FOR DIAGNOSIS AND THERAPEUTIC FOLLOW-UP OF MUSCULAR DYSTROPHIES. HZ043110 - JP 2015510401-A/200: MESENCHYMAL STEM CELLS FOR IN VITRO MODELING AND CELL-BASED THERAPY OF HUMAN DISEASES AND BANKS THEREOF. HZ074164 - JP 2013535982-A/255: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer. HZ081736 - JP 2015514392-A/200: MicroRNAS FOR THE GENERATION OF ASTROCYTES. HZ082768 - JP 2015513906-A/125: Stem Cell Microparticles. HZ157715 - JP 2015130862-A/539: Micromirs. HZ186562 - JP 2015146814-A/311: Oligonucleotides for modulating target RNA activity. HZ436549 - JP 2015529450-A/125: Stem Cell Microparticles. HZ480239 - JP 2015535430-A/745: TERMINALLY MODIFIED RNA. HZ790170 - JP 2016504050-A/1915: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. JA287358 - Sequence 40 from Patent WO2011015720. JA401186 - Sequence 433 from Patent WO2011080318. JA402164 - Sequence 433 from Patent WO2011080315. JA403171 - Sequence 433 from Patent WO2011080316. JA405802 - Sequence 433 from Patent EP2336353. JA427067 - Sequence 400 from Patent WO2011072177. JA429328 - Sequence 433 from Patent WO2011095623. JA667972 - Sequence 51 from Patent WO2011139911. JA808532 - Sequence 4 from Patent WO2012083969. JB022435 - Sequence 277 from Patent WO2013026685. JB022936 - Sequence 190 from Patent WO2013026684. JB233509 - Sequence 41 from Patent EP2437750. JB387962 - Sequence 3 from Patent WO2012041959. JB620340 - Sequence 320 from Patent WO2013063544. JB751155 - Sequence 37 from Patent WO2013087907. JC037525 - Sequence 53 from Patent EP2643479. JC171753 - Sequence 125 from Patent WO2013150303. JC265633 - Sequence 3 from Patent WO2013017542. JC334248 - Sequence 166 from Patent EP2487240. JC512902 - Sequence 3155 from Patent WO2014113089. JC572036 - Sequence 50 from Patent EP2759595. JC572564 - Sequence 125 from Patent WO2014125276. JC582252 - Sequence 125 from Patent WO2014125277. JE869362 - Sequence 3 from Patent WO2015131115. JE953948 - Sequence 125 from Patent WO2015052526. JE955701 - Sequence 125 from Patent WO2015052527. LF132485 - JP 2016506923-A/50: Composition comprising an encapsulated antagomir. LF137453 - JP 2016507550-A/125: Method of Producing Microparticles. LF161010 - JP 2016513950-A/1076: Oligomers with improved off-target profile. LF162418 - JP 2016513095-A/125: Stem Cell Microparticles and miRNA. LF404207 - JP 2015509366-A/200: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS. LF636394 - JP 2016519076-A/168: COMBINATION CANCER TREATMENTS UTILIZING MICRORNA AND EGFR-TKI INHIBITORS. LF838610 - JP 2016530232-A/5: Biomarkers of miR-34 Activity. LF857608 - JP 2015130879-A/57: MICRORNA SIGNATURES IN HUMAN OVARIAN CANCER. LF953170 - JP 2016534103-A/125: Stem Cell Microparticles and miRNA. LG005515 - KR 1020150004822-A/125: STEM CELL MICROPARTICLES. LG046507 - KR 1020150023687-A/52: Oligonucleotide-Based Inhibitors Comprising Locked Nucleic Acid Motif. LG053211 - KR 1020150059168-A/125: STEM CELL MICROPARTICLES. LG134551 - KR 1020150131312-A/169: COMBINATION CANCER TREATMENTS UTILIZING MICRORNAS AND EGFR-TKI INHIBITORS. LG162349 - KR 1020160018451-A/50: Composition comprising an encapsulated antagomir. LG240450 - KR 1020160035087-A/125: STEM CELL MICROPARTICLES AND MIRNA. LP726781 - Sequence 475 from Patent EP2883966. LP819051 - Sequence 475 from Patent EP3296406. LP938993 - Sequence 475 from Patent EP3184651. LQ069375 - Sequence 3 from Patent WO2015153757. LQ070490 - Sequence 814 from Patent EP2964234. LQ278557 - Sequence 96 from Patent WO2016066288. LQ417678 - Sequence 14 from Patent WO2016125163. LQ500643 - Sequence 57 from Patent EP3048177. LQ840942 - Sequence 52 from Patent EP3354734. LV470535 - JP 2016534036-A/125: Stem Cell Microparticles and miRNA. LV539133 - JP 2016539127-A/134: C/EBP ALPHA COMPOSITIONS AND METHODS OF USE. LV746127 - JP 2015521626-A/52: OLIGONUCLEOTIDE-BASED INHIBITORS COMPRISING LOCKED NUCLEIC ACID MOTIF. LY298535 - KR 1020160079824-A/134: C/EBP ALPHA SHORT ACTIVATING RNA COMPOSITIONS AND METHODS OF USE. LY405223 - KR 1020160117535-A/528: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES. LY409558 - KR 1020160122850-A/3: SORAFENIB-MICRORNA COMBINATION THERAPY FOR LIVER CANCER. LZ233919 - JP 2017184756-A/311: Oligonucleotides for modulating target RNA activity. LZ986414 - JP 2017225396-A/16: Complex and use thereof. LZ991535 - WO 2017221875-A/16: COMPLEX AND USE THEREOF. MA260462 - JP 2017505623-A/528: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES. MA264540 - JP 2017507955-A/3: SORAFENIB-MICRORNA COMBINATION THERAPY FOR LIVER CANCER. MA353738 - JP 2018075017-A/200: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS. MS673387 - Sequence 190 from Patent EP3135774. MS816816 - Sequence 165 from Patent WO2017085287. MS834287 - Sequence 433 from Patent EP3112479. MS901804 - Sequence 277 from Patent EP3156505. MS904141 - Sequence 57 from Patent EP3138926. FW364248 - Oligonucleotides for modulating target RNA activity. FW504817 - COMPOSITIONS COMPRISING MIR34 THERAPEUTIC AGENTS FOR TREATING CANCER. HI508168 - Sequence 37 from Patent EP2152722. HI965149 - Sequence 434 from Patent WO2010139812. HI965724 - Sequence 44 from Patent WO2010139811. HI966590 - Sequence 44 from Patent WO2010139810. HV595157 - JP 2010539959-A/538: Micromirs. HW060378 - JP 2012527478-A/42: Identification of MicroRNAs Involved in Post-Myocardial Infarction Remodeling and Heart Failure. HW101965 - JP 2013500034-A/92: Use of microRNA for treating diseases associated with a dysfunction of the cilia in multiciliated epithelial cells. HW505501 - JP 2014502606-A/403: MELANOMA TREATMENTS. HZ074165 - JP 2013535982-A/256: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer. HZ083048 - JP 2015513906-A/405: Stem Cell Microparticles. HZ157714 - JP 2015130862-A/538: Micromirs. HZ186561 - JP 2015146814-A/310: Oligonucleotides for modulating target RNA activity. HZ436829 - JP 2015529450-A/405: Stem Cell Microparticles. HZ480238 - JP 2015535430-A/744: TERMINALLY MODIFIED RNA. HZ790169 - JP 2016504050-A/1914: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. JA287410 - Sequence 92 from Patent WO2011015720. JA401187 - Sequence 434 from Patent WO2011080318. JA402165 - Sequence 434 from Patent WO2011080315. JA403172 - Sequence 434 from Patent WO2011080316. JA405803 - Sequence 434 from Patent EP2336353. JA427033 - Sequence 366 from Patent WO2011072177. JA429329 - Sequence 434 from Patent WO2011095623. JA791780 - Sequence 182 from Patent WO2012089772. JB022567 - Sequence 409 from Patent WO2013026685. JB023060 - Sequence 314 from Patent WO2013026684. JB049959 - Sequence 46 from Patent WO2013020926. JB074879 - Sequence 139 from Patent WO2012168448. JB233510 - Sequence 42 from Patent EP2437750. JB387963 - Sequence 4 from Patent WO2012041959. JB620341 - Sequence 321 from Patent WO2013063544. JC172033 - Sequence 405 from Patent WO2013150303. JC512901 - Sequence 3154 from Patent WO2014113089. JC572035 - Sequence 49 from Patent EP2759595. JC572844 - Sequence 405 from Patent WO2014125276. JC582532 - Sequence 405 from Patent WO2014125277. JE954228 - Sequence 405 from Patent WO2015052526. JE955981 - Sequence 405 from Patent WO2015052527. LF132484 - JP 2016506923-A/49: Composition comprising an encapsulated antagomir. LF137733 - JP 2016507550-A/405: Method of Producing Microparticles. LF161478 - JP 2016513950-A/1544: Oligomers with improved off-target profile. LF162698 - JP 2016513095-A/405: Stem Cell Microparticles and miRNA. LF644433 - JP 2016144439-A/24: Method for assessing cell aging. LF953450 - JP 2016534103-A/405: Stem Cell Microparticles and miRNA. LG005795 - KR 1020150004822-A/405: STEM CELL MICROPARTICLES. LG053491 - KR 1020150059168-A/405: STEM CELL MICROPARTICLES. LG162348 - KR 1020160018451-A/49: Composition comprising an encapsulated antagomir. LG240730 - KR 1020160035087-A/405: STEM CELL MICROPARTICLES AND MIRNA. LP714633 - Sequence 5 from Patent WO2015092707. LP726350 - Sequence 44 from Patent EP2883966. LP818620 - Sequence 44 from Patent EP3296406. LP938562 - Sequence 44 from Patent EP3184651. LQ070489 - Sequence 813 from Patent EP2964234. LQ417679 - Sequence 15 from Patent WO2016125163. LQ441132 - Sequence 139 from Patent EP3029157. LV470815 - JP 2016534036-A/405: Stem Cell Microparticles and miRNA. LY405222 - KR 1020160117535-A/527: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES. LZ233918 - JP 2017184756-A/310: Oligonucleotides for modulating target RNA activity. MA260461 - JP 2017505623-A/527: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES. MS673511 - Sequence 314 from Patent EP3135774. MS834288 - Sequence 434 from Patent EP3112479. MS901936 - Sequence 409 from Patent EP3156505. MS930512 - Sequence 5 from Patent EP3178943. MA643991 - JP 2017113010-A/1915: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. MA731875 - JP 2017140048-A/745: TERMINALLY MODIFIED RNA. MA643990 - JP 2017113010-A/1914: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. MA731874 - JP 2017140048-A/744: TERMINALLY MODIFIED RNA. MA784179 - WO 2018194089-A/2: GENE-MODIFIED COXSACKIEVIRUS AND PHARMACEUTICAL COMPOSITION. LQ955726 - Sequence 57 from Patent EP2775001. LQ932800 - Sequence 24 from Patent EP2802207. MP045487 - Sequence 309 from Patent EP3401394. MP084157 - Sequence 309 from Patent EP3401393. MP045378 - Sequence 200 from Patent EP3401394. MP075719 - Sequence 58 from Patent WO2019002265. MP084048 - Sequence 200 from Patent EP3401393. MP070491 - Sequence 88 from Patent WO2018231851. MA801044 - JP 2018183181-A/1915: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. MA801043 - JP 2018183181-A/1914: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. MP129225 - Sequence 125 from Patent EP3470073. MP162148 - Sequence 125 from Patent WO2019069093. MP174436 - Sequence 21 from Patent WO2019058253. MP129505 - Sequence 405 from Patent EP3470073. MP162428 - Sequence 405 from Patent WO2019069093. MA896109 - JP 2017217007-A/52: OLIGONUCLEOTIDE-BASED INHIBITORS COMPRISING LOCKED NUCLEIC ACID MOTIF. MP280639 - Sequence 59 from Patent WO2019111197. MP283552 - Sequence 59 from Patent WO2019111198. MB420656 - JP 2019154320-A/24: Method for evaluating cell quality. MB453667 - JP 2018509178-A/233: Methods for Highly Parallel and Accurate Measurement of Nucleic Acids.
| |
|
|
Other Names for This Gene
|
|
Alternate Gene Symbols: BC021736 UCSC ID: uc001pll.3 Representative RNA: BC021736
| |
|
|
Gene Model Information
|
|
category:
| noncoding
| nonsense-mediated-decay:
| no
| RNA accession:
| BC021736.1
|
exon count:
| 2 | CDS single in 3' UTR:
| no
| RNA size:
| 1162 |
ORF size:
| 0 | CDS single in intron:
| no
| Alignment % ID:
| 99.74 |
txCdsPredict score:
| 550.50 | frame shift in genome:
| no
| % Coverage:
| 98.28 |
has start codon:
| no
| stop codon in genome:
| no
| # of Alignments:
| 1 |
has end codon:
| no
| retained intron:
| no
| # AT/AC introns
| 0 |
selenocysteine:
| no
| end bleed into intron:
| 0 | # strange splices:
| 0 |
|
Click here
for a detailed description of the fields of the table above.
| |
|
|
Methods, Credits, and Use Restrictions
|
|
Click here
for details on how this gene model was made and data restrictions if any.
| |
|
|
|